EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Bibliographic Details
Title: EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
Authors: Isshiki, Yusuke 1, Chen, Xi 1, 10, Teater, Matt 1, 2, 10, Karagiannidis, Ioannis 1, Nam, Henna 1, Cai, Winson 3, Meydan, Cem 2, 4, Xia, Min 1, Shen, Hao 1, Gutierrez, Johana 1, Easwar Kumar, Vigneshwari 1, Carrasco, Sebastián E. 5, 6, Ouseph, Madhu M. 5, Yamshon, Samuel 1, Martin, Peter 1, Griess, Ofir 7, Shema, Efrat 7, Porazzi, Patrizia 8, Ruella, Marco 8, Brentjens, Renier J. 3, 9, Inghirami, Giorgio 5, Zappasodi, Roberta 1, Chadburn, Amy 5, Melnick, Ari M. 1, Béguelin, Wendy 1, 11, ∗
Source: In Cancer Cell 13 January 2025 43(1):49-68
Database: ScienceDirect
More Details
ISSN:15356108
DOI:10.1016/j.ccell.2024.11.006
Published in:Cancer Cell
Language:English